What’s new: cannabinoids, mindfulness, and the depression-arthritis connection.
Mark L. Fuerst
(1) Menopause worsens RA symptoms; (2) obesity increases disease activity in women with lupus; and (3) signs of cardiac disease appear early in SLE.
(1) Questionable efficacy of knee injections, (2) a dramatic increase in the prevalence of osteoarthritis, and (3) a promising molecular biomarker.
Here: the impact of vitamin D, the Mediterranean diet, and psychological stress on disease severity.
Similarities between ankylosing spondylitis and non-radiographic axial SpA, a caveat about positive MRI scans, and the impact of obesity on disease outcomes.
Two recent studies underscore the key role of interferon in SLE; a third trial identifies a link between undiagnosed vertebral fractures and organ damage in women with lupus.
The gout-dementia connection, daily medication reminders, and the impact of interleukin-1β inhibition on gout attacks.
Drawbacks of bisphosphonate holidays, bone benefits of the Mediterranean diet, and a new weapon against glucocorticoid-induced osteoporosis.
What’s new: advances in serodiagnostic testing, role of T cell activation in Lyme arthritis, and post-treatment Lyme disease syndrome.
Researchers have set their sights on macrophage activation syndrome, pathways identified in renal cells, and mechanistic target of rapamycin.